You are here:

Eli Lilly and Company Ltd

Name SMC ID No Status Sub. Type
 
atomoxetine (Strattera) 1107/15 Restricted Abbreviated Submission
Atomoxetine (Strattera®) 153/05 Superseded Resubmission
Atomoxetine (Strattera®) 153/05 Not Recommended Full submission
baricitinib (Olumiant) 1265/17 Restricted Full submission
drotrecogin alfa [activated] (Xigris®) 13/02 Withdrawn Full submission
dulaglutide (Trulicity) 1110/15 Restricted Full submission
duloxetine (Cymbalta) 514/08 Not Recommended Non submission
Duloxetine (Yentreve®) 119/04 Restricted Full submission
duloxetine 30mg and 60mg capsules (Cymbalta) 285/06 Restricted Full submission
Duloxetine 30mg, 60mg capsules (Cymbalta®) 195/05 Restricted Full submission
exenatide (Bydureon) 748/11 Restricted Full submission
exenatide (Byetta) 684/11 Restricted Full submission
exenatide 5 or 10 micrograms, solution for injection, prefilled pen (Byetta) 376/07 Restricted Full submission
gemcitabine 200mg and 1g powder for solution for infusion (Gemzar) 154/05 Restricted Resubmission
Gemcitabine/paclitaxel (Gemzar®) 154/05 Not Recommended Full submission
ixekizumab (Taltz) 1223/17 Restricted Full submission
necitumumab (Portrazza) 1184/16 Not Recommended Non submission
Olanzapine (Zyprexa) 98/04 Accepted Full submission
Olanzapine (Zyprexa®) 44/03 Restricted Full submission
Olanzapine (Zyprexa®) 106/04 Accepted Full submission
olanzapine long acting injection (ZypAdhera) 624/10 Not Recommended Full submission
olaratumab (Lartruvo) 1273/17 Restricted Full submission
pemetrexed (Alimta) 531/09 Full submission
pemetrexed (Alimta) 531/09 Not Recommended Resubmission
pemetrexed (Alimta) 531/09 Restricted Resubmission
pemetrexed (Alimta) 642/10 Not Recommended Full submission
pemetrexed (Alimta) 770/12 Not Recommended Non submission
pemetrexed (Alimta) 770/12 Accepted Full submission
Pemetrexed (Alimta) 268/06 Not Recommended Non submission
pemetrexed (Alimta) 342/07 Not Recommended Resubmission
pemetrexed (Alimta) 342/07 Restricted Resubmission
Pemetrexed 500mg infusion (Alimta®) 192/05 Superseded Full submission
pemetrexed, 500mg, powder for reconstitution (Alimta) 342/07 Not Recommended Full submission
ramucirumab (Cyramza) 1156/16 Not Recommended Non submission
ramucirumab (Cyramza) 1176/16 Not Recommended Non submission
tadalafil (Adcirca) 710/11 Accepted Full submission
tadalafil (Cialis) 849/12 Not Recommended Non submission
Tadalafil (Cialis®) 40/03 Accepted Full submission
teriparatide (Forsteo) 490/08 Not Recommended Full submission
Teriparatide (Forsteo®) 71/03 Superseded Full submission
teriparatide 20 micrograms/80 microlitres, solution for injection, in prefilled pen (Forsteo) 487/08 Not Recommended Non submission

Back